Abstract
Background: 7–hydroxy–14H–naphtho[2,3–a]phenothiazine–8,13–dione (AQATP) was synthesized by using iodobenzenediacetate as catalyst from 1,4–dihydroxyanthraquinone (1,4–AQ) which was isolated from Cassia tora seeds. Methods: They were then characterized by various spectral techniques. Single crystal X-ray diffraction studies revealed that AQATP crystallizes in orthorhombic space group. ADME Test was performed to determine pharmacokinetic parameter using MedChem designer software. The In silico docking studies were performed to find out the anticancer effect of 1,4–AQ and AQATP using iGEMDOCK software taking CK2 protein as the target. In silico anti-inflammatory study was also carried out by means of the same software taking COX–2 and LOX–5 enzymes as the targets. Results: It was found that the derivative exhibited more binding affinity than the parent compound for both anticancer and anti-inflammatory activities. In vitro anticancer activity in colon cancer cell lines, anti-inflammatory activity by denaturation, COX and LOX assay were performed on AQATP. Conclusion: Results from both computational and in vitro analysis suggest that structural modification of 1,4–AQ could be considered as a good strategy to obtain a lead molecule for drug discovery.
Keywords: Anticancer, anti-inflammatory, AQATP, cassia tora, docking studies, 1, 4–dihydroxyanthraquinone.
Drug Delivery Letters
Title:Synthesis, Single Crystal Study, in silico Analysis, in vitro Antiinflammatory and Anticancer Activities of 7-hydroxy-14H-naphtho[2,3- a]phenothiazine-8,13-dione
Volume: 5 Issue: 2
Author(s): Shiny P. Laila, Annette Fernandez, Arun Kumar, Viswanadhan S. Vishnu, Rema D. Krishnan, Archana P. Das and Ompallil Thomas
Affiliation:
Keywords: Anticancer, anti-inflammatory, AQATP, cassia tora, docking studies, 1, 4–dihydroxyanthraquinone.
Abstract: Background: 7–hydroxy–14H–naphtho[2,3–a]phenothiazine–8,13–dione (AQATP) was synthesized by using iodobenzenediacetate as catalyst from 1,4–dihydroxyanthraquinone (1,4–AQ) which was isolated from Cassia tora seeds. Methods: They were then characterized by various spectral techniques. Single crystal X-ray diffraction studies revealed that AQATP crystallizes in orthorhombic space group. ADME Test was performed to determine pharmacokinetic parameter using MedChem designer software. The In silico docking studies were performed to find out the anticancer effect of 1,4–AQ and AQATP using iGEMDOCK software taking CK2 protein as the target. In silico anti-inflammatory study was also carried out by means of the same software taking COX–2 and LOX–5 enzymes as the targets. Results: It was found that the derivative exhibited more binding affinity than the parent compound for both anticancer and anti-inflammatory activities. In vitro anticancer activity in colon cancer cell lines, anti-inflammatory activity by denaturation, COX and LOX assay were performed on AQATP. Conclusion: Results from both computational and in vitro analysis suggest that structural modification of 1,4–AQ could be considered as a good strategy to obtain a lead molecule for drug discovery.
Export Options
About this article
Cite this article as:
Laila P. Shiny, Fernandez Annette, Kumar Arun, Vishnu S. Viswanadhan, Krishnan D. Rema, Das P. Archana and Thomas Ompallil, Synthesis, Single Crystal Study, in silico Analysis, in vitro Antiinflammatory and Anticancer Activities of 7-hydroxy-14H-naphtho[2,3- a]phenothiazine-8,13-dione, Drug Delivery Letters 2015; 5 (2) . https://dx.doi.org/10.2174/221030310502151214165344
DOI https://dx.doi.org/10.2174/221030310502151214165344 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Foramen Ovale in Cerebral Infarction
Current Cardiology Reviews The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development
Current Pharmaceutical Design Molecular Mechanisms Involved in the Aging of the T-cell Immune Response
Current Genomics Healing the Diabetic Heart: Modulation of Cardiometabolic Syndrome through Peroxisome Proliferator Activated Receptors (PPARs)
Current Molecular Pharmacology Aspirin and Clopidogrel: A Sweeping Combination in Cardiology
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Red Wine, Arterial Stiffness and Central Hemodynamics
Current Pharmaceutical Design A Comprehensive and Contemporary Review on Immunosuppression Therapy for Heart Transplantation
Current Pharmaceutical Design Myopericarditis, as the First Sign of Rheumatoid Arthritis Relapse, Evaluated by Cardiac Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Insulin Resistance as a Therapeutic Target for Improved Endothelial Function:Metformin
Current Drug Targets - Cardiovascular & Hematological Disorders Cytokines as Regulators of Atherosclerosis in Murine Models
Current Drug Targets Endothelial Dysfunction in Hyperglycemia as a Trigger of Atherosclerosis
Current Diabetes Reviews Platelets in Alzheimer’s Disease-Associated Cellular Senescence and Inflammation
Current Pharmaceutical Design The Potential Impact of Sirtuin 1 Protein on Premature Ovarian Insufficiency
Current Proteomics Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus
Current Medicinal Chemistry Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Current Pharmaceutical Design Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)
Current Pharmacogenomics and Personalized Medicine Phentermine and Topiramate Extended-Release for the Obesity: New Kids on the Block
Recent Patents on Cardiovascular Drug Discovery Cardiovascular Disease in Juvenile Idiopathic Arthritis
Current Vascular Pharmacology Arsenic Immunotoxicity and Immunomodulation by Phytochemicals: Potential Relations to Develop Chemopreventive Approaches
Recent Patents on Inflammation & Allergy Drug Discovery Atherosclerosis, Degenerative Aortic Stenosis and Statins
Current Drug Targets